Doxapram HCl CAS 7081-53-0
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
7081-53-0
Name
Doxapram HCl
Synonyms
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate [ACD/IUPAC Name]
1-Éthyl-4-[2-(4-morpholinyl)éthyl]-3,3-diphényl-2-pyrrolidinone, chlorhydrate, hydrate [French] [ACD/IUPAC Name]
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinonhydrochloridhydrat [German] [ACD/IUPAC Name]
1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate
204-022-3 [EINECS]
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride, hydrate (1:1:1) [ACD/Index Name]
7081-53-0 [RN]
Dopram [Trade name] [Wiki]
Doxapram Hydrochloride
Doxapram Hydrochloride hydrate
Doxapram monohydrochloride monohydrate
P5RU6UOQ5Y
Stimulexin
UNII:P5RU6UOQ5Y
(±)-doxapram hydrochloride monohydrate
[7081-53-0]
113-07-5 [RN]
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one and hydron and chloride and hydrate
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydron;chloride;hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate(8CI)
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochloride
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride
1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochloride
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochloride, hydrate(1:1:1)
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate (9CI)
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride monohydrate
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride–water (1/1)
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, monohydrochloride, monohydrate
4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chloride–water (1/1)
Dopram hydrochloride hydrate
Dopram hydrochloride hydrate;Stimulex hydrochloride hydrate;Respiram hydrochloride hydrate
Doxapram (hydrochloride hydrate)
DOXAPRAM HCL
Doxapram hydrochloride monohydrate
Doxapram Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)
hydrate
Hydrochloride
HYDROGEN DOXAPRAM HYDRATE CHLORIDE
MFCD09954698
Respiram hydrochloride hydrate
Stimulex hydrochloride hydrate
Molecular Structure

Structure of Doxapram HCl CAS 7081-53-0
SMILES
CCN1CC(C(C1=O)(c2ccccc2)c3ccccc3)CCN4CCOCC4.O.Cl
StdInChI
InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3;1H;1H2
StdInChIKey
ZOMBFZRWMLIDPX-UHFFFAOYSA-N
Molecular Formula
C24H30N2O2.HCl.H2O
Molecular Weight
432.99
Properties
Appearance
White to off-white crystalline powder
Melting Point
Around 220℃
Safety Data
Symbol
Signal Word
Danger
Hazard Statements
Precautionary Statements
RIDADR
UN 2811 6.1 / PGIII
WGK Germany
3
Specifications and Other Information of Our Doxapram HCl CAS 7081-53-0
Standard
USP38
Identification Methods
IR,UV
Assay
98.0%~100.5%
Heavy Metals
≤20ppm
pH
3.5~5.0
Loss on Drying
3.0%~4.5%
Residue on Ignition
≤0.3%
Organic Impurities
≤0.2%
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
It is commonly used for respiratory depression caused by central inhibitory drugs, acute respiratory failure, COPD complicated with acute respiratory failure, and accelerated wake-up after anesthesia.
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/doxapram-hcl-cas-7081-53-0/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/doxapram-hcl-cas-7081-53-0/